ACHV 8-K 2026-10-01
ACHIEVE LIFE SCIENCES, INC. (ACHV) 8-K dated 2026-10-01 — accession 0001193125-26-410781.
ACHIEVE LIFE SCIENCES, INC. (ACHV) is a biotechnology company listed on NASDAQ.
ACHIEVE LIFE SCIENCES, INC. filed a 8-K on 2026-10-01. Accession 0001193125-26-410781.
This 8-K covers: Director/officer change (Item 5.02). SEC EDGAR holds the official filing and its exhibits.
Latest reported ACHV revenue for 2019-12-31 was $0. Net income was -$16.4M. ACHV currently screens at market cap $569.1M.
Not investment advice. The ACHV SEC hub lists recent forms. The stock page is the research view.